- Home
- NPCT vs ZNTL Comparison
NPCT vs ZNTL Comparison
Compare NPCT & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$4.17
Company Overview
Basic Information| Metric | NPCT | ZNTL |
|---|---|---|
| Founded | 2020 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 286.7M | 289.0M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NPCT | ZNTL |
|---|---|---|
| Price | $9.82 | $4.17 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $6.60 |
| AVG Volume (30 Days) | 119.1K | ★ 1.2M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 9.82% | N/A |
| EPS Growth | N/A | ★ 18.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.65 | $1.21 |
| 52 Week High | $11.12 | $6.95 |
Technical Indicators
Market Signals| Indicator | NPCT | ZNTL |
|---|---|---|
| Relative Strength Index (RSI) | 49.92 | 41.86 |
| Support Level | $9.80 | $3.53 |
| Resistance Level | $10.16 | $4.23 |
| Average True Range (ATR) | 0.08 | 0.39 |
| MACD | 0.02 | -0.07 |
| Stochastic Oscillator | 70.86 | 13.60 |
Price Performance
Historical Comparison NPCT
ZNTL
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of current income.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.